You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 2, 23 JANUARY 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antithrombotic Therapy

An Abbreviated Reference for Clinicians

Richard C. Becker, MD; Jack Ansell, MD

Arch Intern Med. 1995;155(2):149-161.


Abstract

Antithrombotic therapy is a mainstay in the treatment of patients with thromboembolic diseases of the arterial and venous circulatory systems. Continued work and investigation has provided much-needed information directly applicable to meeting high standards of patient care. The American College of Chest Physicians Consensus Conference on Antithrombotic Therapy has been instrumental in developing guidelines. This article is a synopsis of the proposed guidelines, including recent updates and information that will likely influence future receommendations.

(Arch Intern Med. 1995;155:149-161)



Author Affiliations

From the Department of Medicine, University of Massachusetts Medical Center, Worcester (Dr Becker), and the Departments of Medicine and Pathology, Boston (Mass) University Medical Center (Dr Ansell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty
Lieberman and Hsu
JBJS 2005;87:2097-2112.
ABSTRACT | FULL TEXT  

Use of specific indicators to detect warfarin-related adverse events
Hartis et al.
Am J Health Syst Pharm 2005;62:1683-1688.
ABSTRACT | FULL TEXT  

Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment
Milic et al.
Europace 2005;7:374-379.
ABSTRACT | FULL TEXT  

New Evidence for Stroke Prevention: Scientific Review
Straus et al.
JAMA 2002;288:1388-1395.
ABSTRACT | FULL TEXT  

Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part II): Recommendations for Antithrombotic Therapy
Baker
CLIN APPL THROMB HEMOST 1998;4:143-147.
ABSTRACT  

Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I)
Baker
CLIN APPL THROMB HEMOST 1998;4:51-75.
ABSTRACT  

Management of Anticoagulation before and after Elective Surgery
Kearon and Hirsh
NEJM 1997;336:1506-1511.
FULL TEXT  

Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation
Gage et al.
JAMA 1995;274:1839-1845.
ABSTRACT  

Antithrombotic Therapy in Acute Ischemic Stroke
Dorman et al.
Arch Intern Med 1995;155:2481-2481.
ABSTRACT  

Intravenous Vitamin K1 Injections: Dangerous Prophylaxis
O'Reilly and Kearns
Arch Intern Med 1995;155:2127-2127.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.